Perspectives on integrated continuous bioprocessing — opportunities and challenges
暂无分享,去创建一个
[1] Konstantin B Konstantinov,et al. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.
[2] Marcella Yu,et al. Effects of cell culture conditions on antibody N‐linked glycosylation—what affects high mannose 5 glycoform , 2011, Biotechnology and bioengineering.
[3] Jemelle Dizon-Maspat,et al. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production , 2012, Biotechnology and bioengineering.
[4] Mohamed Al-Rubeai,et al. Bioreactor systems for the production of biopharmaceuticals from animal cells , 2006, Biotechnology and applied biochemistry.
[5] Alois Jungbauer,et al. Preparative continuous annular chromatography (P-CAC), a review , 2002, Bioprocess and biosystems engineering.
[6] Konstantin B Konstantinov,et al. The future of industrial bioprocessing: batch or continuous? , 2015, Biotechnology and bioengineering.
[7] G. Carta,et al. Unfolding and aggregation of a glycosylated monoclonal antibody on a cation exchange column. Part II. Protein structure effects by hydrogen deuterium exchange mass spectrometry. , 2014, Journal of chromatography. A.
[8] Alois Jungbauer,et al. Continuous downstream processing of biopharmaceuticals. , 2013, Trends in biotechnology.
[9] R Fuchs,et al. Practical Considerations in Operation and Scale‐up of Spin‐Filter Based Bioreactors for Monoclonal Antibody Production , 1996, Biotechnology progress.
[10] A. Livingston,et al. Continuous purification of active pharmaceutical ingredients using multistage organic solvent nanofiltration membrane cascade , 2014 .
[11] Daniel Cummings,et al. Integrated continuous production of recombinant therapeutic proteins , 2012, Biotechnology and bioengineering.
[12] F Meuwly,et al. Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells , 2003, Biotechnology and bioengineering.
[13] Suzanne S Farid,et al. Continuous bioprocessing: The real thing this time? , 2014, mAbs.
[14] Massimo Morbidelli,et al. A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process , 2007, Biotechnology and bioengineering.
[15] Marco Rito-Palomares,et al. Continuous aqueous two-phase systems devices for the recovery of biological products , 2014 .
[16] M. Lay,et al. Continuous Radial Flow Chromatography of Proteins , 2006 .
[17] Andrew L. Zydney,et al. Bioprocess membrane technology , 2007 .
[18] M. Perc,et al. Resolution of the Stochastic Strategy Spatial Prisoner's Dilemma by Means of Particle Swarm Optimization , 2011, PloS one.
[19] Andrew L. Zydney,et al. Continuous downstream processing for high value biological products: A Review , 2016, Biotechnology and bioengineering.
[20] Bernd Kammerer,et al. Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale , 2011, PloS one.
[21] Nitin Yadav,et al. Avoiding antibody aggregation during processing: Establishing hold times , 2014, Biotechnology journal.
[22] Hongcheng Liu,et al. Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.
[23] J. Birch,et al. Large-scale cell culture in biotechnology. , 1986, Science.
[24] Melissa A. Holstein,et al. Downstream bioprocessing: recent advances and future promise , 2011 .
[25] Anurag S Rathore,et al. Continuous Processing for Production of Biopharmaceuticals , 2015, Preparative biochemistry & biotechnology.
[26] Allan S. Myerson,et al. Continuous Plug Flow Crystallization of Pharmaceutical Compounds , 2010 .
[27] Andrew D. Tustian,et al. Purification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography. , 2015, Journal of biotechnology.
[28] Gintaras V. Reklaitis,et al. Process systems engineering: From Solvay to modern bio- and nanotechnology.: A history of development, successes and prospects for the future , 2011 .
[29] Matthias Wessling,et al. In situ product recovery: Submerged membranes vs. external loop membranes , 2012 .
[30] José P. S. Aniceto,et al. Simulated Moving Bed Strategies and Designs: From Established Systems to the Latest Developments , 2015 .
[31] J. O’Connell,et al. Unfolding of a model protein on ion exchange and mixed mode chromatography surfaces. , 2014, Journal of chromatography. A.
[32] S. Lute,et al. Analysis of viral clearance unit operations for monoclonal antibodies , 2010, Biotechnology and bioengineering.
[33] Alois Jungbauer,et al. Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation. , 2014, Biotechnology journal.
[34] Jason Walther,et al. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. , 2015, Journal of biotechnology.
[35] Frank Riske,et al. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins. , 2012, Biotechnology journal.
[36] Jason Condon,et al. Understanding and modeling alternating tangential flow filtration for perfusion cell culture , 2014, Biotechnology progress.
[37] Suresh Vunnum,et al. Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1). , 2012, Journal of chromatography. A.